Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.95% | 5.75% | 0.35% | 11.13% | 9.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.95% | 5.75% | 0.35% | 11.13% | 9.30% |
| Cost of Revenue | 0.57% | 1.41% | 2.62% | 12.91% | 13.43% |
| Gross Profit | 7.43% | 10.03% | -1.69% | 9.38% | 5.34% |
| SG&A Expenses | 0.94% | 1.47% | 8.14% | 10.80% | -14.66% |
| Depreciation & Amortization | -11.02% | -11.06% | -9.45% | -0.28% | -2.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.16% | 0.84% | 4.35% | 11.25% | -0.32% |
| Operating Income | 42.98% | 49.89% | -40.75% | -17.94% | 17,845.83% |
| Income Before Tax | 70.67% | 67.54% | -52.59% | -104.39% | 133.48% |
| Income Tax Expenses | 62.22% | -2.74% | 280.54% | 109.57% | 278.77% |
| Earnings from Continuing Operations | 74.83% | 182.91% | -69.19% | -104.89% | 124.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.83% | 182.91% | -69.19% | -104.89% | 124.02% |
| EBIT | 42.98% | 49.89% | -40.75% | -17.94% | 17,845.83% |
| EBITDA | 28.26% | 34.20% | -24.78% | -9.68% | 173.58% |
| EPS Basic | 75.00% | 183.33% | -69.39% | -102.71% | 111.37% |
| Normalized Basic EPS | 69.84% | 68.35% | -52.63% | -102.40% | 115.83% |
| EPS Diluted | 75.00% | 183.33% | -69.39% | -103.06% | 111.09% |
| Normalized Diluted EPS | 69.84% | 68.35% | -52.63% | -102.40% | 115.83% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 81.20% | 111.64% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 81.20% | 111.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
